AK006
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AK006, covering 2025-06-03 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 [Phase 1]